Tag Archives: Pill

Does a common heart attack pill help everyone? Studies disagree  Reuters Common heart attack drug doesn’t work and may raise risk of death for some women, new studies say  CNN Doctors may need to rethink decades of routine beta blocker use for some patients after a heart attack, studies suggest  ABC News Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF  TCTMD.com Common …

The next big obesity medication coming down the pipeline will likely come in pill form. Eli Lilly has just released the latest positive Phase III trial results of its experimental oral GLP-1 drug, orforglipron. On Tuesday morning, Eli Lilly reported that orforglipron met the benchmarks of the company’s Phase III ATTAIN-2 study. People taking orforglipron experienced substantial improvements in weight …

Novo Nordisk (NVO) stock was down on Tuesday, despite a lack of news from the pharmaceutical company. Instead, investors can turn to rival drug maker Eli Lilly (LLY) to learn why shares of NVO stock have fallen today. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights …

U.S. pharmaceutical giant Eli Lilly (LLY) says it is preparing for the approval and launch of its new weight loss pill following the results of a late-stage clinical trial. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The Indianapolis, Indiana-based …

Lilly pill cuts body weight by 10.5% in patients with type 2 diabetes  Reuters Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval  CNBC Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity  Eli Lilly and Company Eli Lilly’s weight-loss pill meets target in key …

Eli Lilly Ready to Seek Obesity Pill Green Light After Study Hits Goals  The Wall Street Journal Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval  CNBC Eli Lilly Says New Pill Results in 10.5% Weight-Loss for Diabetes Patients. The Stock Is Up.  Barron’s Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory …

Eli Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023. Mike Blake | Reuters Eli Lilly on Tuesday said its daily weight loss pill helped patients with obesity and Type 2 diabetes shed weight in a late-stage trial, meeting the study’s main goal and clearing the way for the company to file for approval of the …

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly‘s stock is still recovering after the drugmaker released trial data earlier this month on its closely watched obesity pill that underwhelmed Wall Street. In a key late-stage trial, Eli Lilly’s pill, orforglipron, caused …

A South Texas woman who was arrested on murder charges in 2022 after using medication to terminate her pregnancy has alleged new details about her case against a local sheriff and prosecutors, claiming they violated her constitutional rights. Her Aug. 12 court filing comes as the debate over medicated abortion is heating up in Texas, with Attorney General Ken Paxton …

Key Takeaways Viking Therapeutics reported a large number of patients dropped out of a study of its experimental weight-loss pill. Overall, 28% of those taking VK2735 left the Phase 2 trial early compared with 18% among placebo subjects. The research showed the pill reduced the weight of patients who took it for 13 weeks by up to 26.7 pounds. Viking …